Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedOvarian cancer was added as a topic, and related topics now include MedlinePlus Genetics. The site revision version was updated from 3.6.3 to 3.6.4.SummaryDifference0.2%

- Check18 days agoChange DetectedThe related topics section removes 'Ovarian cancer' and 'MedlinePlus Genetics', reducing contextual links while leaving the core study information unchanged.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAddition of the disease topic 'Ovarian cancer' and a 'related topics' section linking to MedlinePlus Genetics. A revision note updates the site metadata from Revision: v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check39 days agoChange DetectedA new site revision label, Revision: v3.6.2, was added. The page also removed the Ovarian cancer and MedlinePlus Genetics related topics as well as the older Revision: v3.6.0 reference from the related topics and revision notes.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows that recruitment has closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revised Intervention/Treatment heading, while removing the old heading and the prior revision reference.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision: v3.5.5 replaces v3.5.4. This reflects a new build of the page without changes to study content.SummaryDifference0.1%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.